Keros Therapeutics Inc. shares lost over three-quarters of their market capitalization on Thursday, marking an all-time low, ...

Keros Therapeutics said on Thursday it had paused giving patients higher doses of its high blood pressure treatment in a mid-stage study after reports of a safety issue, sending its shares plunging 77 ...